CANbridge Pharmaceuticals appoints Carrie Ann Cook new SVP/global head of Business Development
17 June 2020 -

CANbridge Pharmaceuticals Inc, a China-based biopharmaceutical company, has named Carrie Ann Cook as its new senior vice-president/global head of Business Development effective 8 June, it was reported on Tuesday.

Cook has over 20 years of experience in the pharmaceutical industry. Prior to joining CANbridge Pharmaceuticals she was senior director, Center for External Innovation, Rare Disease. She was also head of Global Business Development & Licensing, MS, Medical Devices and Global Health at EMD Serono Inc, in Billerica, Massachusetts. She has held various positions of increasing responsibility in business development and marketing in many organisations.

James Xue, PhD, founder, chairman and CEO, CANbridge Pharmaceuticals Inc, said, 'Carrie's extensive international business development experience and excellent strategic track record make her a standout. She is ideal to lead the CANbridge global business development team as we advance as a world-class biopharmaceutical company driven by a rare disease-focused strategy.'